Clay B Siegal is the primary founder of Seattle Genetics and is currently the company’s president, C.E.O, and company’s board chairman. Seattle Genetics, with the leadership of siegall, is the world leader in developing antibody-drug conjugates, and in collaboration with Takeda Pharmaceutical Company, it is now a global brand. These drugs are used to treat cancer. Before founding Seattle Genetics, he has worked with the Bristol-Myers Squibb Pharmaceutical Research Institute from 1991, and also the National Cancer Institute. Seattle Genetics aims to offer patients with treatment therapies, conduct extensive research on cancer illness, and develop drugs that treat cancer patients through new research methodologies.
He has authored more than 70 publications and holds 15 patents highlighting his achievements and experiences. He has a Ph.D. from George Washington University and a B.S in Zoology from the University of Maryland. In mid-2013, he was appointed as a member of the board of Mirna Therapeutics, a biotechnology firm involved in development and commercialization of microRNA. microRNA-based therapeutics are used in cancer research.
Dr Siegalls contribution to cancer cannot be taken for granted since all the firm’s listed above as having an interest in, deal with cancer research. He also has extensive education on genetics, which is essential in the treatment of cancer. He revealed his plans in a publication interview in Bizjournals where he laid his plans for drug development. The George Washington Medicine and Health Blog reported that siegall became interested in Cancer treatment after his father got diagnosed with brain cancer.
His searches on social media are laced with photos of Seattle Genetics employees celebrating the achievements of the company, and also of his family members lauding him for his contributions. He also posts articles talking about Cancer and how people should respond to cancer ailments. He also encourages individuals to get checked such that if diagnosed with cancer, they can start receiving treatment and slow the cancer spread in the body.